1. Ng, S. C. 2015. Emerging leadership lecture: Inflammatory bowel disease in Asia: emergence of a "Western" disease. Journal of Gastroenterology and Hepatology 30 (3):440-445.
2. Ng, S. C., Z. Zeng, O. Niewiadomski, W. Tang, S. Bell, M. A. Kamm, P. Hu et al. . 2016. Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. Gastroenterology 150 (1):86-95
3. Bopanna, S., A. N. Ananthakrishnan, S. Kedia, V. Yajnik, and V. Ahuja. 2017. Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. The lancet. Gastroenterology & hepatology 2 (4):269-276.
4. Ungaro, R., S. Mehandru, P. B. Allen, L. Peyrin-Biroulet, and J. F. Colombel. 2017. Ulcerative colitis. Lancet 389 (10080):1756-1770.
5. Ohnmacht, C, J. H Park, S Cording, J. B Wing, K Atarashi, Y Obata, V Gaboriau-Routhiau et al. . 2015. MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells. Science (New York, N.Y.) 349 (6251):989-993.
6. E., Sefik, Geva-Zatorsky N., Oh S., Konnikova L., Zemmour D., McGuire AM., Burzyn D. et al. . 2015. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ regulatory T cells. Science (New York, N.Y.) 349 (6251):993-997.
7. Grégoire, C., C. Lechanteur, A. Briquet, É. Baudoux, F. Baron, E. Louis, and Y. Beguin. 2017. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics 45 (2):205-221.
8. Liu, J. Y., L. J. Zhang, and M. Y. Liu. 2019. Mechanisms supporting potential use of bone marrow-derived mesenchymal stem cells in psychocardiology. American Journal of Translational Research 11 (11):6717-6738.
9. El Agha, E., R. Kramann, R. K. Schneider, X. Li, W. Seeger, B. D. Humphreys, and S. Bellusci. 2017. Mesenchymal Stem Cells in Fibrotic Disease. Cell Stem Cell 21 (2):166-177.
10. Ciccocioppo, R., A. Gallia, A. Sgarella, P. Kruzliak, P. G. Gobbi, and G. R. Corazza. 2015. Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow–Derived Mesenchymal Stem Cells. Mayo Clinic Proceedings 90 (6):747-755.
11. Zuo, D., X. Liu, Z. Shou, H. Fan, Q. Tang, X. Duan, D. Cao, Z. Zou, and L. Zhang. 2013. Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory Tcells for the treatment of experimental colitis. International Journal of Molecular Medicine. 32 (6):1337-1344.
12. Nan, Z., H. Fan, Q. Tang, M. Zhang, M. Xu, Q. Chen, Y. Liu, Y. Dong, H. Wu, and S. Deng. 2018. Dual expression of CXCR4 and IL-35 enhances the therapeutic effects of BMSCs on TNBS-induced colitis in rats through expansion of Tregs and suppression of Th17 cells. Biochemical and Biophysical Research Communications 499 (4):727-734.
13. Shi, L., S. Chen, L. Yang, and Y. Li. 2013. The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies. Journal of Hematology & Oncology 6 (1):74.
14. Dai, S., R. Jia, X. Zhang, Q. Fang, and L. Huang. 2014. The PD-1/PD-Ls pathway and autoimmune diseases. Cellular Immunology 290 (1):72-79.
15. Sun, C., R. Mezzadra, and T. N. Schumacher. 2018. Regulation and Function of the PD-L1 Checkpoint Immunity 48 (3):434-452.
16. Francisco, L. M., V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman, V. K. Kuchroo, and A. H. Sharpe. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. The Journal of Experimental Medicine 206 (13):3015–3029.
17. Sheng, H., Y. Wang, Y. Jin, Q. Zhang, Y. Zhang, L. Wang, B. Shen et al. . 2008. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Research 18 (8):846-857.
18. Davies, L. C., N. Heldring, N. Kadri, and K. Le Blanc. 2017. Mesenchymal Stromal Cell Secretion of Programmed Death‐1 Ligands Regulates T Cell Mediated Immunosuppression. Stem Cells 35 (3):766-776.
19. Gui, X., J. Li, A. Ueno, M. Iacucci, J. Qian, and S. Ghosh. 2018. Histopathological Features of Inflammatory Bowel Disease are Associated With Different CD4+ T Cell Subsets in Colonic Mucosal Lamina Propria. Journal of Crohn's & Colitis 12 (12):1448–1458.
20. Schardey, J., A. M. Globig, C. Janssen, M. Hofmann, P. Manegold, R. Thimme, and P. Hasselblatt. 2019. Vitamin D Inhibits Pro-Inflammatory T Cell Function in Patients With Inflammatory Bowel Disease. Journal of Crohn's & Colitis 13 (12):1546–1557.
21. Dalal, J., K. Gandy, and J. Domen. 2012. Role of mesenchymal stem cell therapy in Crohn's disease. Pediatric Research 71 (4 Pt 2):445-451.
22. Hu, F., B. Sun, P. Xu, Y. Zhu, X. H. Meng, G. J. Teng, and Z. D. Xiao. 2017. MiR-218 Induces Neuronal Differentiation of ASCs in a Temporally Sequential Manner with Fibroblast Growth Factor by Regulation of the Wnt Signaling Pathway. Scientific Reports 7:39427.
23. Allbright, K. O., J. M. Bliley, E. Havis, D. Y. Kim, G. A. Dibernardo, D. Grybowski, M. Waldner et al. . 2018. Delivery of adipose‐derived stem cells in poloxamer hydrogel improves peripheral nerve regeneration. Muscle & Nerve 58 (2):251–260.
24. Zuo, D., Q. Tang, H. Fan, Z. Shou, X. Liu, D. Cao, and Z. Zou. 2015. Modulation of nuclear factor-κB-mediated pro-inflammatory response is associated with exogenous administration of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis. Molecular Medicine Reports 11 (4):2741-2748.
25. Wang, Y., Z. Shou, H. Fan, M. Xu, Q. Chen, Q. Tang, X. Liu et al. . 2019. Protective effects of oxymatrine against DSS-induced acute intestinal inflammation in mice via blocking the RhoA/ROCK signaling pathway. Bioscience Reports 39 (7):BSR20182297.
26. Chen, Q., X. Duan, M. Xu, H. Fan, Y. Dong, H. Wu, M. Zhang et al. . 2020. BMSC-EVs regulate Th17 cell differentiation in UC via H3K27me3. Molecular Immunology 118:191-200.
27. Sun, M., C. He, Y. Cong, and Z. Liu. 2015. Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. Mucosal immunology 8 (5):969-978.
28. Imam, T., S. Park, M. H. Kaplan, and M. R. Olson. 2018. Effector T Helper Cell Subsets in Inflammatory Bowel Diseases. Frontiers in Immunology 9:1212.
29. Xu, M., X. Y. Duan, Q. Y. Chen, H. Fan, Z. C. Hong, S. J. Deng, Z. Nan et al. . 2019. Effect of compound sophorae decoction on dextran sodium sulfate (DSS)-induced colitis in mice by regulating Th17/Treg cell balance. Biomedicine & Pharmacotherapy 109:2396-2408.
30. Zhang, M., H. Fan, S. Tan, Q. Tang, X. Liu, D. Zuo, Y. Liao, Z. Nan, and C. Tan. 2020. The Chinese medicinal herb decoction QRZSLXF enhances anti-inflammatory effect in TNBS-induced colitis via balancing Th17/Tregs differentiation. Journal of Ethnopharmacology 251:112549.
31. Casiraghi, F., N. Azzollini, P. Cassis, B. Imberti, M. Morigi, D. Cugini, R. A. Cavinato et al. . 2008. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. The Journal of immunology 181 (6):3933-3946.
32. Rhee, K. J., J. I. Lee, and Y. W. Eom. 2015. Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression. International Journal of Molecularences 16 (12):30015-30033.
33. Raptopoulou, A. P., G. Bertsias, D. Makrygiannakis, P. Verginis, I. Kritikos, M. Tzardi, L. Klareskog, A. I. Catrina, P. Sidiropoulos, and D. T. Boumpas. 2010. The programmed death 1/programmed death ligand 1 inhibitory pathway is up‐regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Arthritis & Rheumatism 62 (7):1870-1880.
34. Brusa, D., S. Serra, M. Coscia, D. Rossi, G. D'Arena, L. Laurenti, O. Jaksic et al. . 2013. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia. Haematologica 98 (6):953-963.
35. Gao, H., J. Zhang, and X. Ren. 2019. PD-L1 regulates tumorigenesis and autophagy of ovarian cancer by activating mTORC signaling. Bioscience Reports 39 (12):BSR20191041.
36. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annual review of immunology 26:677-704.
37. Jin, H. T., R. Ahmed, and T. Okazaki. 2011. Role of PD-1 in regulating T-cell immunity. Current Topics in Microbiology & Immunology 350:17-37.
38. Battaglia, M., A. Stabilini, B. Migliavacca, J. Horejs-Hoeck, T. Kaupper, and M. G. Roncarolo. 2006. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. The Journal of immunology 177 (12):8338-8347.
39. Coenen, J. J., H. J. Koenen, E. van Rijssen, A. Kasran, L. Boon, L. B. Hilbrands, and I. Joosten. 2007. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells. Bone Marrow Transplantation 39 (9):537-545.
40. Sauer, S., L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z. A. Knight et al. . 2008. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proceedings of the National Academy of Sciences of the United States of America 105 (22):7797-7802.
41. Hofmeyer, K. A., H. Jeon, and X. Zang. 2011. The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion. Journal of Biomedicine & Biotechnology 2011:451694.